Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 1 · newest first

  1. Proportion, Histopathological Spectrum, and Clinicopathological Characteristics of Soft Tissue Sarcomas in Cameroon: A Sixteen-Year Retrospective Registry-Based StudyCancer Treatment and Research Communications · 2026
  2. Assessment of Peripheral and Tumor Specific Tregs and Th17 cells in Patients with Endometrial CancerCancer Treatment and Research Communications · 2026
  3. Rethinking cardiovascular risk stratification in TKI-treated chronic myeloid leukemiaCancer Treatment and Research Communications · 2026
  4. ACTR5 as a Potential Therapeutic Target in AML: Preliminary Mechanistic Insights from Integrated Multi-Omics AnalysisCancer Treatment and Research Communications · 2026
  5. Theranostic strategies in prostate cancer: Advances in PSMA PET imaging and radioligand therapyCancer Treatment and Research Communications · 2026
  6. Visceral adipose tissue inflammation in endometrial cancerCancer Treatment and Research Communications · 2026
  7. Mapping the evidence of stereotactic body radiotherapy combined with systemic therapy in oligometastatic and oligoprogressive non-small cell lung cancer: A visual synthesis of clinical outcomes and toxicityCancer Treatment and Research Communications · 2026
  8. Alternative bevacizumab schedule in high-grade gliomas recurrence is associated with reductions in greenhouse gas emissions without loss of clinical efficacyCancer Treatment and Research Communications · 2026
  9. Projected disease burden and treatment eligibility of patients with diffuse large B-cell and mantle cell lymphoma in the United States over the next decadeCancer Treatment and Research Communications · 2026
  10. Efficacy and safety of underwater endoscopic mucosal resection (UEMR) for non-pedunculated colorectal polyps: a prospective study IN VietnamCancer Treatment and Research Communications · 2026
  11. Management of high-risk biochemical recurrence in prostate cancer: A GCC Delphi consensus (BEAM Panel)Cancer Treatment and Research Communications · 2026
  12. Elevated risks of all-cause mortality and distant metastasis in breast cancer patients with vitamin D deficiency: a population-based analysisCancer Treatment and Research Communications · 2026
  13. HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validationCancer Treatment and Research Communications · 2026
  14. The potential of B7-H3 as a new target for CAR-T therapy: Advancements, challenges and clinical perspectivesCancer Treatment and Research Communications · 2026
  15. Dietary fiber and total fat intake density and self-reported cancer history in U.S. adults: NHANES 2021–2022Cancer Treatment and Research Communications · 2026
  16. Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international studyCancer Treatment and Research Communications · 2026
  17. Brentuximab vedotin in cutaneous T-Cell lymphoma: emerging evidence and therapeutic insights for CD30-negative and CD30-low diseaseCancer Treatment and Research Communications · 2026
  18. Histone methylation machinery in gliomas: From enzymatic mechanisms to inhibitor developmentCancer Treatment and Research Communications · 2026
  19. Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective studyCancer Treatment and Research Communications · 2026
  20. Association between body mass index and high grade cervical intraepithelial neoplasia (CIN 2/3) in a dysplasia referral populationCancer Treatment and Research Communications · 2026
  21. Emerging role of interaction between m6A and main ncRNAs in pancreatic cancerCancer Treatment and Research Communications · 2026
  22. Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world dataCancer Treatment and Research Communications · 2026
  23. Advances in the management of small cell lung cancer: thoracic and cranial radiation therapy and sequencing with systemic therapyCancer Treatment and Research Communications · 2026
  24. Investigation of the Relationship Between Autophagy and Warburg Effect in Osteosarcoma Cells: An in Vitro StudyCancer Treatment and Research Communications · 2026
  25. CRI-CCTG-0003/IND.240 An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)Cancer Treatment and Research Communications · 2026
  26. Concurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression and lung adenocarcinoma: A Case Report and literature reviewCancer Treatment and Research Communications · 2026
  27. Patient Survival Outcomes in Brain Metastases of Pancreatic Ductal Adenocarcinoma: A Comprehensive AnalysisCancer Treatment and Research Communications · 2026
  28. RPL32: From Housekeeping Gene to Potential Biomarker and Therapeutic Target in Cancer and Multiple System DiseasesCancer Treatment and Research Communications · 2026
  29. Tolerability and Effectiveness of Definitive Chemoradiotherapy in Locally Advanced Lung Cancer Patients with Combined Pulmonary Fibrosis and EmphysemaCancer Treatment and Research Communications · 2026
  30. Pegfilgrastim versus Filgrastim for Chemo-Mobilized Stem Cell Collection in Multiple Myeloma: A Retrospective Real-World StudyCancer Treatment and Research Communications · 2026
  31. EpCAM: A Multifunctional Protein at the Crossroads of Cancer Biology, Diagnosis, and ImmunotherapyCancer Treatment and Research Communications · 2026
  32. Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition eraCancer Treatment and Research Communications · 2026
  33. Neutrophil-to-Lymphocyte Ratio and Performance Status Are Associated With Increased Risk of Skin Toxicity in Patients Receiving Enfortumab Vedotin With or Without Pembrolizumab for Metastatic Urothelial CarcinomaCancer Treatment and Research Communications · 2026
  34. Immunotoxin Therapy: A Promising Frontier in Targeted Cancer Treatment a Review of Clinical Trials in Hematological and Solid TumorsCancer Treatment and Research Communications · 2026
  35. A simple clinical risk score can predict frailty in HNSCC patientsCancer Treatment and Research Communications · 2026
  36. Cervical Cancer in the Arab World: Knowledge Gaps, Health System and Cultural Barriers, and the Path ForwardCancer Treatment and Research Communications · 2026
  37. Normal kidney tissue derived extracellular vesicles suppress clear cell renal cell carcinoma progression via transfer their inhibitory miRNAsCancer Treatment and Research Communications · 2026
  38. Viral Modulation of the CXCL12/CXCR4/CXCR7 Axis: Mechanisms, Impacts on Immunity and Oncogenesis, and Therapeutic OpportunitiesCancer Treatment and Research Communications · 2026
  39. Primary prevention of skin cancer in patients after kidney transplantation – a literature reviewCancer Treatment and Research Communications · 2026
  40. Real-world Perioperative Systemic Treatment Patterns and Outcomes in Patients with Urothelial Carcinoma Undergoing Radical SurgeryCancer Treatment and Research Communications · 2026
  41. Precision Breast Oncology: Molecular Insights and Transformative Clinical StrategiesCancer Treatment and Research Communications · 2026
  42. Distinct Roles of WHO Score, CCI, and CFS in Prognosis and Treatment Decisions for Non-Small Cell Lung Cancer: A Retrospective Real-World StudyCancer Treatment and Research Communications · 2026
  43. Incidence of Common Cancers in Georgia in 2015–2019: A National Cancer Registry StudyCancer Treatment and Research Communications · 2026
  44. Prolonged Sequential Temozolomide in Glioblastoma: A Systematic Review with Exploratory Quantitative SynthesisCancer Treatment and Research Communications · 2026
  45. The potential clinical benefit of routine comprehensive genomic profiling in non-small cell lung cancer for the detection of prognostic co-mutations – a multicenter next generation sequencing studyCancer Treatment and Research Communications · 2026
  46. Evaluation of Guideline-Recommended Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer Patients who underwent Next-Generation Sequencing Testing: Results from a Real-World StudyCancer Treatment and Research Communications · 2026
  47. LINC02057 as a potential tumor marker for the aggressive renal cell carcinomaCancer Treatment and Research Communications · 2026
  48. Fluorescent Chromophores in Anticancer Therapy: Mechanisms and AdvancesCancer Treatment and Research Communications · 2026
  49. KRAS G12C Inhibitor Outcomes in Advanced Non-Small Cell Lung Cancer by Smoking History, Performance Status, and KEAP1 Mutation StatusCancer Treatment and Research Communications · 2026
  50. “HPV 16/18 E6 DNA and mRNA expression in Gross cervical lesions: A Hospital based cross-sectional study from Sikkim, India.”Cancer Treatment and Research Communications · 2026